"How long the negotiations will go in the WTO to agree on the text. That will be key because we need the things right now. "Details of the text will be important as there should not be any conditions, which could make it difficult for developing countries like India and South Africa to manufacture vaccines. The devil lies in the details," Biswajit Dhar, professor of economics at Jawaharlal Nehru University, said. He added that all the things required to treat and contain Covid-19 should be free from IPR (Intellectual Property Rights) incumbrances. National Intellectual Property Organisation (NIPO) President T.C. James said the words in the text would be key and the WTO member countries should soon start the negotiations on that. "Technology is important here, IPR is not that big thing. We need to encourage more competition among pharma companies," James said.